Literature DB >> 7002793

Quantitation of antibody against cell wall mannan and a major cytoplasmic antigen of Candida in rabbits, mice, and humans.

J M Jones.   

Abstract

Cell wall mannan of type A Candida albicans was purified, conjugated with tyramine, and labeled with 125I. Labeled cell wall mannan was used in a radioimmunoassay to measure serum antimannan antibody levels. An ammonium sulfate-soluble fraction of a cytoplasmic extract of C. albicans contained a large amount of a major cytoplasmic antigen of this organism. When the sulfate-soluble fraction was labeled with 125I, much more 125I attached to this major antigen than to the other antigens present in the sulfate-soluble fraction. Thus, when serum antisulfate-soluble fraction antibody levels were measured by a radioimmunoassay which used the iodine-labeled sulfate-soluble fraction, antibody against this major cytoplasmic antigen was quantitated. Both radioimmunoassays were used to measure antimannan and antisulfate-soluble fraction antibody levels in mice, rabbits, and humans. Irrespective of the procedure used to elicit antibody against C. albicans antigens, mice failed to produce antimannan antibody. By contrast, all strains of mice tested produced antisulfate-soluble fraction antibody after immunization, and the magnitude of this antibody response depended on the strain of mice immunized. Rabbits readily produced antibody against both mannan and sulfate-soluble fraction when immunized by a variety of methods. Antimannan antibody was detected in 100% of sera from a randomly selected sample of 50 hospitalized patients. Only 1 of 50 patients had antisulfate-soluble fraction antibody detectable by radioimmunoassay. In pooled normal human serum, most antimannan antibody was of the immunoglobulin G class.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7002793      PMCID: PMC551280          DOI: 10.1128/iai.30.1.78-89.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  23 in total

1.  Kinetics of the antibody response to type III pneumococcal polysaccharide (SSS-III). I. Use of 125I-labeled SSS-III to study serum antibody levels, as well as the distribution and excretion of antigen after immunization.

Authors:  J M Jones; D F Amsbaugh; B Prescott
Journal:  J Immunol       Date:  1976-01       Impact factor: 5.422

2.  Immune studies in candidiasis. 3. Precipitating antibodies in systemic candidiasis.

Authors:  C L Taschdjian; P J Kozinn; L Caroline
Journal:  Sabouraudia       Date:  1964-10

3.  Serologic diagnosis of disseminated candidiasis in patients with acute leukemia.

Authors:  H D Preisler; H F Hasenclever; A A Levitan; E S Henderson
Journal:  Ann Intern Med       Date:  1969-01       Impact factor: 25.391

4.  Passive immunization of mice against Candida albicans.

Authors:  S Mourad; L Friedman
Journal:  Sabouraudia       Date:  1968-02

5.  Cell wall composition of the mycelial and blastospore forms of Candida albicans.

Authors:  F W Chattaway; M R Holmes; A J Barlow
Journal:  J Gen Microbiol       Date:  1968-05

6.  Clinical application of counterimmunoelectrophoresis in detection of Candida serum precipitins.

Authors:  T H Dee; M W Rytel
Journal:  J Lab Clin Med       Date:  1975-01

7.  Anti-Candida factors in serum and their inhibitors. I. Clinical and laboratory observations.

Authors:  D B Louria; J K Smith; R G Brayton; M Buse
Journal:  J Infect Dis       Date:  1972-02       Impact factor: 5.226

8.  Mannan antigenemia in the diagnosis of invasive Candida infections.

Authors:  M H Weiner; W J Yount
Journal:  J Clin Invest       Date:  1976-11       Impact factor: 14.808

9.  Primary interaction between antibody and components of Alternaria. I. Immunology and chemical characteristics of labeled antigens.

Authors:  M J Schumacher; J K McClatchy; R S Farr; P Minden
Journal:  J Allergy Clin Immunol       Date:  1975-07       Impact factor: 10.793

10.  Binding between components of the tubercle bacillus and humoral antibodies.

Authors:  P Minden; R S Farr
Journal:  J Exp Med       Date:  1969-11-01       Impact factor: 14.307

View more
  31 in total

Review 1.  Adherence and receptor relationships of Candida albicans.

Authors:  R A Calderone; P C Braun
Journal:  Microbiol Rev       Date:  1991-03

2.  Value of detection of antibodies to Candida albicans germ tube in the diagnosis of systemic candidosis.

Authors:  G Quindós; J Pontón; R Cisterna; D W Mackenzie
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-03       Impact factor: 3.267

3.  Mannan as an antigen in cell-mediated immunity (CMI) assays and as a modulator of mannan-specific CMI.

Authors:  J E Domer; R E Garner; R N Befidi-Mengue
Journal:  Infect Immun       Date:  1989-03       Impact factor: 3.441

4.  Evaluation of cross-reactions in Histoplasma capsulatum serologic tests.

Authors:  J Wheat; M L French; S Kamel; R P Tewari
Journal:  J Clin Microbiol       Date:  1986-03       Impact factor: 5.948

5.  Biological activities of naturally occurring antibodies reactive with Candida albicans mannan.

Authors:  Thomas R Kozel; Randall S MacGill; Ann Percival; Qing Zhou
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

6.  Demonstration and solubilization of antigens expressed primarily on the surfaces of Candida albicans germ tubes.

Authors:  E H Smail; J M Jones
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

Review 7.  New developments in the diagnosis of opportunistic fungal infection.

Authors:  V Hopwood; D W Warnock
Journal:  Eur J Clin Microbiol       Date:  1986-08       Impact factor: 3.267

8.  Gastric colonization with Candida albicans.

Authors:  R A Greenfield; W A Joyce
Journal:  Mycopathologia       Date:  1993-04       Impact factor: 2.574

9.  Analysis of cell wall extracts of Candida albicans by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and Western blot techniques.

Authors:  J Ponton; J M Jones
Journal:  Infect Immun       Date:  1986-09       Impact factor: 3.441

10.  Isolation, purification, and radiolabeling of a novel 120-kD surface protein on Blastomyces dermatitidis yeasts to detect antibody in infected patients.

Authors:  B S Klein; J M Jones
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.